Ind Swift| Pharmaceutical Formulations Development | Pharmaceuticals Manufacturer | Indian Pharma Companies

Our Networks
National International
Marketing
Domestic Marketing International Marketing Distribution & Logistics Contact Us
R & D
Objectives Products Developed Achievements R&D Infrastructure Future Plans
Our Divisions
Cardia Swift Division Generic Division Gyno Swift Division Institution Division Mega Swift Division Oncrit Division Proposed Divisions Q-den Division
Why Choose Us
Our Presence Strengths Rankings Awards Production Major Break Throughs Products In Pipeline
Investors
Board OF Directors Share Holding Patterns Quarterly Results Annual Reports Corporate Governance Code of Conduct Live Stock In NSE Live Stock in BSE Unclaimed Dividends Unclaimed Deposit
Career
Work Culture Career & Growth Employee Benefits HR Contact Details Current Openings Application Form
Media Center
Corporate Film Corporate Brochure Presentation Annual Reports e-Newsletter Image Gallery Ind-Swift in News ISL Empire 2013
CSR

Formulations Development

Research & Development

Products Developed

R & D Infrastructure


Development of NDDS
Development of non infringing process.
Development of different Netazoxanide dosage forms .
New process development for cost effectiveness
Trouble shooting in plant.
Performance batches.
NCMR handling
Bioequivalence and bioavailability as per DCI and International guidelines .
	Drug regulatory affair and documentation: Dossiers for ANDA’s of different countries, NDA's filing in India, patents filing after a thorough scrutiny by attorneys, documentation for getting USFDA, documentation for R & D products , documentation for commercial samples, documentation for bioequivalence samples.
Contract Research from conceptualization till the final dossier of the product.